GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析

◆英語タイトル:GenMark Diagnostics Inc (GNMK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011699
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis. The company offers educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

GenMark Diagnostics Inc (GNMK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GenMark Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
Equity Offering 12
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc – Key Competitors 20
GenMark Diagnostics Inc – Key Employees 21
GenMark Diagnostics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 02, 2017: GenMark Diagnostics Reports Third Quarter 2017 Results 23
Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 24
May 02, 2017: GenMark Diagnostics Reports First Quarter 2017 Results 25
Feb 28, 2017: GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results 26
Jan 10, 2017: GenMark Announces Preliminary Q4 2016 Financial Results 27
Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results 28
Jul 28, 2016: GenMark Diagnostics Reports Q2 Financial Results 29
May 03, 2016: GenMark Reports First Quarter 2016 Results 30
Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results 31
Jan 12, 2016: GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex Analytical Studies 32
Legal and Regulatory 33
Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive and Gram-Negative Panels 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
GenMark Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc, Key Competitors 20
GenMark Diagnostics Inc, Key Employees 21

★海外企業調査レポート[GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■

◆H&Iグローバルリサーチ株式会社のお客様(例)◆